- 15-20 minutes per injection
- 1-2 days per injection; ongoing monthly/bimonthly treatments
- 69%
China versus the U.S.
- China clinical rate
- $500 – $2,000
- $1,250
- United States
- $2,000 – $6,000
- $4,000
- You save
- ~69%
- $2,750 per procedure
Prices are approximate ranges. Actual cost depends on hospital, surgeon, materials, and case complexity.
What the procedure involves.
Anti-VEGF intravitreal injections are the gold standard treatment for wet age-related macular degeneration (AMD), diabetic macular edema, and retinal vein occlusion. Chinese retinal specialists administer these injections using internationally approved agents (ranibizumab, aflibercept) as well as effective biosimilar options at lower cost. Treatment preserves and often improves central vision when started promptly.
Step by step.
Retinal Diagnosis
OCT scan, fluorescein angiography, and visual acuity assessment to confirm active neovascularization or edema
Intravitreal Injection
Topical anesthesia, sterile preparation, and precise injection of anti-VEGF medication into the vitreous cavity
Post-injection Check
Intraocular pressure check, visual acuity confirmation, and instructions for monitoring symptoms
Treatment Monitoring
Monthly OCT imaging to assess response and determine need for repeat injection on treat-and-extend protocol
- Preserves and often improves central vision
- Well-established safety profile with millions of injections worldwide
- Biosimilar options significantly reduce per-injection cost in China
- Treat-and-extend protocols reduce injection frequency over time
- Endophthalmitis (very rare, ~1 in 3000)
- Elevated intraocular pressure
- Retinal detachment (rare)
- Need for ongoing repeated injections
Ask the AI for hospitals that handle anti-vegf injection (amd treatment).
Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.